• 1
    Roach M, Lu J, Pilepich MV, et al. Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys. 2000; 47: 609615.
  • 2
    Grossfeld JD, Yu-Ping L, Lubeck DP, Carroll PR. Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy. Urology. 2002; (S) 3A: 5763.
  • 3
    Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA. 1997; 277: 467471.
  • 4
    Hanks GE, Hanlon AL, Epstein B, Horwitz EM. Dose response in prostate cancer with 8–12 years' follow-up. Int J Radiat Oncol Biol Phys. 2002; 54: 427435.
  • 5
    Sylvester JE, Blasko JC, Grimm PD, Meier R, Malmgren JA. Ten-year biochemical relapse free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. Int J Radiat Oncol Biol Phys. 2003; 57: 944952.
  • 6
    Kuban DA, Thames HD, Levy LB, et al. Long-term multi-institutional analysis of Stage T1–T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2003; 57: 915928.
  • 7
    Kneebone A, Turner S, Berry M, Cakir B, Gebski V. Australian prostate specific antigen outcome and toxicity following radiation therapy for localized prostate cancer. Australas Radiol. 2003; 47: 422427.
  • 8
    Cox JD, Grignon DJ, Kaplan RS, Parsons JT, Schellhammer PF. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 1997; 37: 10351041.
  • 9
    Almroth A, Ljung G, Eklund T, et al. Value of sextant biopsies in the assessment of local cure following external beam radiotherapy of prostatic adenocarcinoma. Scand J Urol Nephrol. 1998; 32: 111115.
  • 10
    Hanks GE, Krall JM, Martz KL, Diamond JJ, Kramer S. The outcome of treatment of 313 patients with T-1 (UICC) prostate cancer treated with external beam irradiation. Int J Radiat Oncol Biol Phys. 1988; 14: 243248.
  • 11
    Freiha FS, Bagshaw MA. Carcinoma of the prostate: results of post-irradiation biopsy. Prostate. 1984; 5: 1925.
  • 12
    Roach M, Lu J, Pilepich MV, et al. Long-term survival after radiotherapy alone: Radiation Therapy Oncology Group prostate cancer trials. J Urol. 1999; 161: 864868.
  • 13
    Rosser CJ, Levy LB, Kuban DA, et al. Hazard rates for disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate. J Urol. 2003; 169: 21602165.
  • 14
    Zietman AL, Chung CS, Coen JJ, Shipley WU. Ten-year outcome for men with localize prostate cancer treated with external radiation therapy: results of a cohort study. J Urol. 2004; 171: 210214.
  • 15
    Maartense S, Hermans J, Leer WH. Radiation therapy in localized prostate cancer: long-term results and toxicity. Clin Oncol. 2000; 12: 222228.
  • 16
    al-Abany M, Helgason AR, Cronqvist AKA, Svensson C, Wersall P, Steineck G. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields. Acta Oncol. 2002; 41: 532542.
  • 17
    Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA. Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys. 2000; 48: 643647.